Neuromyelitis optica
Clinical trials for Neuromyelitis optica explained in plain language.
Never miss a new study
Get alerted when new Neuromyelitis optica trials appear
Sign up with your email to follow new studies for Neuromyelitis optica, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can CRISPR-Edited cells stop autoimmune attacks on the brain?
Cure Not yet recruitingThis trial tests a therapy called CTX112 in adults with severe neurologic autoimmune diseases, including progressive multiple sclerosis, neuromyelitis optica, and stiff-person syndrome. CTX112 uses donor T cells edited with CRISPR to target and deplete B cells, which are thought …
Matched conditions: NEUROMYELITIS OPTICA
Phase 1/2 • Sponsor: CRISPR Therapeutics • Aim: Cure
Last updated Sep 11, 2026 00:00 UTC
-
New hope for rare nerve disease: can a biologic drug cut steroid use?
Disease control Not yet recruitingThis study tests a drug called inebilizumab combined with a fast steroid taper in 25 people newly diagnosed with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the optic nerves and spinal cord. The goal is to see if this approach can reduce…
Matched conditions: NEUROMYELITIS OPTICA
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 15:16 UTC